Eligibility Prostate Cancer NCT00777959

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
confirmed adenocarcinomas of the prostate.
Beschrijving

Adenocarcinoma of prostate

Datatype

boolean

Alias
UMLS CUI [1]
C0007112
evidence of metastatic disease
Beschrijving

Neoplasm Metastasis

Datatype

boolean

Alias
UMLS CUI [1]
C0027627
evidence of disease progression including one of the following: increasing levels of psa, progressive lymph node disease, or worsening bone scan
Beschrijving

Disease Progression | Raised prostate specific antigen | Disorder of lymph node Progressive | Bone scan Worsening

Datatype

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2]
C0178415
UMLS CUI [3,1]
C0272394
UMLS CUI [3,2]
C0205329
UMLS CUI [4,1]
C0203668
UMLS CUI [4,2]
C0332271
psa level is greater or equal to 7 ng/ml.
Beschrijving

Prostate specific antigen measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0201544
ecog performance status less than or equal to 1
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
exclusion criteria :
Beschrijving

Exclusion Criteria

Datatype

boolean

Alias
UMLS CUI [1]
C0680251
previously received bicalutamide, flutamide, or nilutamide within the past 12 months (except for a period of use less than 30 days long).
Beschrijving

bicalutamide | Flutamide | nilutamide

Datatype

boolean

Alias
UMLS CUI [1]
C0285590
UMLS CUI [2]
C0016384
UMLS CUI [3]
C0068771
prior chemotherapy for prostate cancer
Beschrijving

Prior Chemotherapy Prostate carcinoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0600139
prior rapamycin or rapamycin analogs, including ridaforolimus, everolimus, or temsirolimus.
Beschrijving

Sirolimus | Sirolimus Analogs | ridaforolimus | everolimus | temsirolimus

Datatype

boolean

Alias
UMLS CUI [1]
C0072980
UMLS CUI [2,1]
C0072980
UMLS CUI [2,2]
C0243071
UMLS CUI [3]
C2713007
UMLS CUI [4]
C0541315
UMLS CUI [5]
C1707080
patient is receiving an opioid or narcotic analgesic for pain due to prostate cancer
Beschrijving

Opioids Pain | Narcotic Analgesics Pain | Pain Due to Prostate carcinoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0242402
UMLS CUI [1,2]
C0030193
UMLS CUI [2,1]
C0027409
UMLS CUI [2,2]
C0030193
UMLS CUI [3,1]
C0030193
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C0600139
patient has pain related to prostate cancer that warrants the initiation of chemotherapy
Beschrijving

Pain Relationship Prostate carcinoma | Initiation Chemotherapy Required

Datatype

boolean

Alias
UMLS CUI [1,1]
C0030193
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0600139
UMLS CUI [2,1]
C1704686
UMLS CUI [2,2]
C0392920
UMLS CUI [2,3]
C1514873

Similar models

Eligibility Prostate Cancer NCT00777959

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
confirmed adenocarcinomas of the prostate.
boolean
C0007112 (UMLS CUI [1])
Neoplasm Metastasis
Item
evidence of metastatic disease
boolean
C0027627 (UMLS CUI [1])
Disease Progression | Raised prostate specific antigen | Disorder of lymph node Progressive | Bone scan Worsening
Item
evidence of disease progression including one of the following: increasing levels of psa, progressive lymph node disease, or worsening bone scan
boolean
C0242656 (UMLS CUI [1])
C0178415 (UMLS CUI [2])
C0272394 (UMLS CUI [3,1])
C0205329 (UMLS CUI [3,2])
C0203668 (UMLS CUI [4,1])
C0332271 (UMLS CUI [4,2])
Prostate specific antigen measurement
Item
psa level is greater or equal to 7 ng/ml.
boolean
C0201544 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status less than or equal to 1
boolean
C1520224 (UMLS CUI [1])
Exclusion Criteria
Item
exclusion criteria :
boolean
C0680251 (UMLS CUI [1])
bicalutamide | Flutamide | nilutamide
Item
previously received bicalutamide, flutamide, or nilutamide within the past 12 months (except for a period of use less than 30 days long).
boolean
C0285590 (UMLS CUI [1])
C0016384 (UMLS CUI [2])
C0068771 (UMLS CUI [3])
Prior Chemotherapy Prostate carcinoma
Item
prior chemotherapy for prostate cancer
boolean
C1514457 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
Sirolimus | Sirolimus Analogs | ridaforolimus | everolimus | temsirolimus
Item
prior rapamycin or rapamycin analogs, including ridaforolimus, everolimus, or temsirolimus.
boolean
C0072980 (UMLS CUI [1])
C0072980 (UMLS CUI [2,1])
C0243071 (UMLS CUI [2,2])
C2713007 (UMLS CUI [3])
C0541315 (UMLS CUI [4])
C1707080 (UMLS CUI [5])
Opioids Pain | Narcotic Analgesics Pain | Pain Due to Prostate carcinoma
Item
patient is receiving an opioid or narcotic analgesic for pain due to prostate cancer
boolean
C0242402 (UMLS CUI [1,1])
C0030193 (UMLS CUI [1,2])
C0027409 (UMLS CUI [2,1])
C0030193 (UMLS CUI [2,2])
C0030193 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C0600139 (UMLS CUI [3,3])
Pain Relationship Prostate carcinoma | Initiation Chemotherapy Required
Item
patient has pain related to prostate cancer that warrants the initiation of chemotherapy
boolean
C0030193 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C1704686 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C1514873 (UMLS CUI [2,3])